There should be quite a bit of news to follow over next few months. FDA (INAD) application, CSRIO collaboration, CPAT-01 trial update/result read out, DermaCann trial and possible distribution agreements.
I suspect things could heat up for CP1 in the coming months.
All IMO. DYOR